Inhaled isotretinoin (13-cis retinoic acid) is an effective lung cancer chemopreventive agent in A/J mice at low doses: A pilot study

Clinical Cancer Research

Volumn 6, Issue 8, 2000, Pages 3015-3024

  Dahl, Alan R ^a   Grossi, Irma M ^a   Houchens, David P ^a   Scovell, Laurie J ^a   Placke, Michael E ^a   Imondi, Anthony R ^a   Stoner, Gary D ^b   De Luca, Luigi M ^c   Wang, Dali ^c   Mulshine, James L ^c  

^a BATTELLE MEMORIAL INSTITUTE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; BENZO[A]PYRENE; ISOTRETINOIN; RETINOIC ACID RECEPTOR; URETHAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER PREVENTION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG TOLERABILITY; GENE CONTROL; LUNG ADENOMA; LUNG CANCER; MALE; MOUSE; NONHUMAN; PILOT STUDY; PRIORITY JOURNAL; SKIN TOXICITY;

ADMINISTRATION, INHALATION; ANIMALS; ANTICARCINOGENIC AGENTS; CARCINOGENS; DOSE-RESPONSE RELATIONSHIP, DRUG; ISOTRETINOIN; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED A; PARTICLE SIZE; PILOT PROJECTS; RECEPTORS, RETINOIC ACID; TUMOR MARKERS, BIOLOGICAL;

EID: 0033870353     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Genta, V. M., Kaufman, D. G., Harris, C. C., Smith, J. M., Sporn, M. B., and Saffiotti, U. Vitamin A deficiency enhances binding of benzo(a)pyrene to tracheal epithelial DNA. Nature (Lond.), 247: 48-49, 1974.
2. Hong, W. K., Lippman, S. M., Itri, L. M., Karp, D. D., Lee, J. S., Byers, R. M., Schantz, S. P., Kramer, A. M., Lotan, R., Peters, L. J., Dimery, I. W., Brown, B. W., and Goepfert, H. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N. Engl. J. Med., 323: 795-801, 1990.
3. Benner, S. E., Pajak, T. F., Lippman, S. M., Earley, C., and Hong, W. K. Prevention of second primary tumors with isotretinoin in patients with squamous cell carcinoma of the head and neck: long-term follow-up. J. Natl. Cancer Inst., 86: 140-141, 1994.
4. Wiegand, U-W., and Chou, R. C. Pharmacokinetics of oral isotretinoin. J. Am. Acad. Dermatol., 39: S8-S12, 1998.
5. Lee, J. S., Lippman, S. M., Benner, S. E., Lee, J. J., Ro, J. Y., Lukeman, J. M., Morice, R. C., Peters, E. J., Pang, A. C., Fritsche, H. A., Jr., and Hong, W. K. Randomized placebo-controlled trial of isotretinoin in chemoprevention of bronchial squamous metaplasia. J. Clin. Oncol., 12: 937-945, 1994.
6. Gerde, P., Muggenburg, B. A., Hoover, M. D., and Henderson, R. F. Disposition of polycyclic aromatic hydrocarbons in the respiratory tract of the beagle dog: I. The alveolar region. Toxicol. Appl. Pharmacol., 121: 313-318, 1993.
7. Gerde, P., Muggenburg, B. A., Thornton-Manning, J. R., Lewis, J. L., Pyon, K. H., and Dahl, A. R. Benzo[a]pyrene at an environmentally relevant dose is slowly absorbed by, and extensively metabolized in, tracheal epithelium. Carcinogenesis, 18: 1825-1832, 1997.
8. Avis, I., Mathias, A., Unsworth, E. J., Miller, M-J., Cuttitta, F., Mulshine, J. L., and Jakowlew, S. B. Analysis of small cell lung cancer cell growth inhibition of 13-cis-retinoic acid: importance of bioavailability. Cell Growth Differ., 6: 485-492, 1995.
9. Frasca, J. M., and Garfinkel, L. 13-cis Retinoic acid and murine pulmonary adenomas: a preliminary report. Nutr. Cancer, 3: 72-74, 1981.
10. Malkinson, A. M., and Belinsky, S. A. The use of animal models in preclinical studies. In: H. I. Pass, J. B. Mitchell, D. H. Johnson, and A. T. Turrisi, eds., Lung Cancer: Principles and Practice, pp. 273-284. Philadelphia: Lippincott-Raven Publishers, 1996.
11. You, M., and Bergman, G. Preclinical and clinical models of lung cancer chemoprevention. Hematol. Oncol. Clin. N. Am., 12: 1037-1053, 1998.
12. Lin, L., Festing, M. F. W., Devereux, T. R., Crist, K. A., Christiansen, S. C., Wang, Y., Yang, A., Svenson, K., Paigen, B., Malkinson, A. M., and You, M. Additional evidence that the K-ras protooncogene is a candidate for the major mouse pulmonary adenoma susceptibility (Pas-1) gene. Exp. Lung Res., 24: 481-497, 1998.
13. Belinsky, S. A., Devereux, T. R., Foley, J. F., Maronpot, R. R., and Anderson, M. W. Role of the alveolar type II cell in the development and progression of pulmonary tumors induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the A/J mouse. Cancer Res., 52: 3164-3173, 1992.
14. Horio, Y., Chen, A., Rice, P., Roth, J. A., Malkinson, A. M., and Schrump, D. S. Ki-ras and p53 mutations are early and late events, respectively, in urethane-induced pulmonary carcinogenesis in A/J mice. Mol. Carcinogenesis, 17: 217-223, 1996.
15. Malkinson, A. M. Molecular comparison of human and mouse pulmonary adenocarcinomas. Exp. Lung Res., 24: 541-555, 1998.
16. Hecht, S. S., Morse, M. A., Amin, S., Stoner, G. D., Jordan, K. G., Choi, C-I., and Chung, F-L. Rapid single-dose model for lung tumor induction in A/J mice by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and the effect of diet. Carcinogenesis (Lond.), 10: 1901-1904, 1989.
17. Cannon, W. C., Blanton, E. F., and McDonald, K. E. The flow-past chamber: an improved nose-only exposure system for rodents. Am. Ind. Hyg. Assoc. J., 44: 923-928, 1983.
18. Honn, K. V., Chen, Y. Q., Timar, J., Onoda, J. M., Hatfield, J. S., Fligiel, S. E. G., Steinert, B. W., Diglio, C. A., Grossi, I. M., Nelson, K. K., and Taylor, J. D. αIIb/βIII integrin expression and function in subpopulations of murine tumors. Exp. Cell Res., 201: 23-32, 1992.
19. Onoda, J. M., Nelson, K. K., Grossi, I. M., Umbarger, L. A., Taylor, J. D., and Honn, K. V. Separation of high and low metastatic subpopulations from solid tumors by centrifugal elutriation. Proc. Soc. Exp. Biol. Med., 187: 250-255, 1988.
20. Sloane, B. F., Rozhin, J., Gomez, A. P., Grossi, I. M., and Honn, K. V. Effects of 12-hydroxyeicosatetraenoic acid on release of cathepsin B and cysteine proteinase inhibitors from malignant melanoma cells. In: K. V. Honn, L. J. Marnett, S. Nigam, and T. Walden Jr., eds., Eicosanoids and Other Bioactive Lipids in Cancer and Radiation Injury, pp. 373-378. Boston: Kluwer Academic Pubs., 1991.
21. Chiantore, M. V., Giandomenico, V., and De Luca, L. M. Carcinoma cell lines resistant for growth inhibition and apoptosis to retinoic acid are responsive to 4-hydroxy-phenyl-retinamide: correlation with tissue transglutaminase. Biochem. Biophys. Res. Commun., 254: 636-641, 1999.
22. Giandomenico, V., Andreola, F., Rodriguez de la Concepcion, M. L., Collins, S. J., and De Luca, L. M. Retinoic acid and 4-hydroxyphenyl-retinamide induce growth inhibition and tissue transglutaminase through different signal transduction pathways in mouse fibroblasts (NIH-3T3 cells). Carcinogenesis (Lond.), 20: 1133-1135, 1999.
23. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72: 248-254, 1976.
24. Raabe, O. G., Al-Bayati, M. A., Teague, S. V., and Rasolt, A. Regional deposition of inhaled monodisperse coarse and fine aerosol particles in small laboratory animals. Ann. Occup. Hyg., 32 (Suppl. 1): 53-63, 1988.
25. Guyton, A. C. Measurement of the respiratory volumes of laboratory animals. Am. J. Physiol., 150: 7-77, 1947.
26. Rogers, A. E., Zeisel, S. H., and Groopman, J. Diet and carcinogenesis. Carcinogenesis (Lond.), 14: 2205-2217, 1993.
27. Albanes, D. Total calories, body weight, and tumor incidence in mice. Cancer Res., 47: 1987-1992, 1987.
28. Wattenberg, L. W., Wiedmann, T. S., Estensen, R. D., Zimmerman, C. L., Steele, V. E., and Kelloff, G. J. Chemoprevention of pulmonary carcinogenesis by aerosolized budesonide in female A/J mice. Cancer Res., 57: 5489-5492, 1997.
29. Yamamoto, H., Fuji, K., and Hayakawa, T. Inhibitory effect of cold stress on lung tumors induced by 7,12-dimethylbenzaanthracene in mice. J. Cancer Res. Clin. Oncol., 121: 393-396, 1995.
30. Mulshine, J. L., De Luca, L. M., and Dedrick, R. L. Regional delivery of retinoids: a new approach to early lung cancer intervention. In: Y. Martinet, F. R. Hirsch, N. Martinet, and J. M. Vignaud (eds.), Clinical and Biological Basis of Lung Cancer Prevention, Vol. 24, pp. 273-283. Basel, Switzerland: Birkhauser Verlag, 1998.
31. Wattenberg, L. W., Wiedmann, T. S., Estensen, R. D., Zimmerman, C. L., Galbraith, A. R., Steele, V. E., and Kelloff, G. J. Chemoprevention of pulmonary carcinogenesis by brief exposures to aerosolized budesonide or beclomethasone dipropionate and by the combination of aerosolized budesonide and dietary, myo-inositol. Carcinogenesis (Lond.), 21: 179-182, 2000.
32. Hoffmann, D., and Hoffmann, I. The changing cigarette, 1950-1995. J. Toxicol. Environ. Health, 50; 307-364, 1997.
33. Stoner, G. D. Introduction to mouse lung tumorigenesis. Exp. Lung Res., 24: 375-383, 1998.
34. Gunning, W. T., Castonguay, A., Goldblatt, P. J., and Stoner, G. D. Strain A/J mouse lung adenoma growth patterns vary when induced by different carcinogens. Toxicol. Pathol., 19: 168-174, 1991.
35. Pinkerton, R. E., Gehr, P., and Crapo, J. D. Table 3. Comparative anatomy of the lung parenchyma and air-blood tissue barrier. In: Treatise on Pulmonary Toxicology, Vol. 1, Comparative Biology of the Normal Lung. Boca Raton, FL: CRC Press, 1992.
36. Harkema, J. R. Epithelial cells of the nasal passages. In: R A. Parent (ed.), Comparative Biology of the Normal Lung. Boca Raton, FL: CRC Press, 1992.
37. Miller, F. J. Nasal Toxicity and Dosimetry of Inhaled Xenobiotics: Implications for Human Health. Washington, DC: Taylor & Francis, 1995.
38. Barrow, C. S. Toxicology of the Nasal Passages. New York: Hemisphere Publishing Corporation, 1984.
39. 2 by oncogenic ras in human non-small cell lung cancer. J. Biol. Chem., 272: 14501-14504, 1997.
40. Sheng, H., Williams, C. S., Shao, J., Liang, P., DuBois, R. N., and Beauchamp, R. D. Induction of cyclooxygenase-2 by activated Ha-ras oncogene in Rat-1 fibroblasts and the role of mitogen-activated protein kinase pathway. J. Biol. Chem., 273: 22120-22127, 1998.
41. Hida, T., Yatabe, Y., Achiwa, H., Muramatsu, H., Kozaki, K., Nakamura, S., Ogawa, M., Mitsudomi, T., Sugiura, T., and Takahashi, T. Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res., 58: 3761-3764, 1998.
42. Hida, T., Leyton, J., Makheja, A. N., Ben-Av, P., Hla, T., Martinez, A., Mulshine, J., Malkani, S., Chung, P., and Moody, T. W. Non small cell lung cancer cyclooxygenase activity and proliferation are inhibited by nonsteroidal antiinflammatory drugs. Anticancer Res., 18: 775-782, 1998b.
43. Hong, S. H., Ondrey, F. G., Avis, I. M., Chen, Z., Loukinova, E., Cavanaugh, P. F., Jr., Van Waes, C., and Mulshine, J. L. Cyclooxygenase regulates human oropharyngeal carcinomas via the proinflammatory cytokine IL-6: a general role for inflammation? FASEB J., in press, 2000.
44. Zhou, X. F., Shen, X. Q., and Shemshedini, L. Ligand-activated retinoic acid receptor inhibits AP-1 transactivation by disrupting c-jun/ c-fos dimerization. Mol. Endocrinol., 13: 276-285, 1999.
45. Mestre, J. R., Subbaramaiah, K., Sacks, P. G., Schantz, S. P., Tanabe, T., Inoue, H., and Dannenberg, A. H. Retinoids suppress epidermal growth factor-induced transcription of cyclooxygenase-2 in human oral squamous carcinoma cells. Cancer Res., 57: 2890-2895, 1997.
46. De Luca, L. M., Kosa, K., and Andreola, F. The role of vitamin a in differentiation and skin carcinogenesis. J. Nutr. Biochem., 8: 426-437, 1997.
47. Massaro, G. D., and Massaro, D. Retinoic acid treatment abrogates elastase-induced pulmonary emphysema in rats. Nat. Med., 3: 675-677, 1997.
48. Tockman, M. S., Anthonisen, N. R., Wright, E. C., and Donithan, M. G. Airways obstruction and the risk for lung cancer. Ann. Intern. Med., 106: 512-518, 1987.
49. Albanes, D., Heinonen, O. P., Taylor, P. R., Virtamo, J., Edwards, B. K., Rautalahti, M., Hartman, A. M., Palmgren, J., Freedman, L. S., Haapakoski, J., Barrett, M. J., Pietinen, P., Malila, N., Tala, E., Liippo, K., Salomaa, E. R., Tangrea, J. A., Teppo, L., Askin, F. B., Taskinen, E., Erozan, Y., Greenwald, P., and Huttunen, J. K. α-Tocopherol and β-carotene supplements and lung cancer incidence in the α-tocopherol, β-carotene cancer prevention study: effects of base-line characteristics and study compliance. J. Natl. Cancer Inst., 88: 1560-1570, 1996.
50. Christen, W. G., Gaziano, J. M., and Hennekens, C. H. Design of Physicians' Health Study II - randomized trial of β-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials. Ann. Epidemiol., 10: 125-134, 2000.
51. Omenn, G. S., Goodman, G. E., Thornquist, M. D., Balmes J., Cullen, M. R., Glass, A., Koegh, J. P., Meyskens, F. L., Valanis, B., Williams, J. H., Barnhart, S., and Hammar, S. Effects of a combination of β carotene and vitamin A on lung cancer and cardiovascular disease. N. Engl. J. Med., 334: 1150-1155, 1996.
52. Hong, W. K. The Genetic and Molecular Basis of Chemoprevention: Aerodigestive Cancer as a Model. Fifth AACR - Joseph H. Burchenal Clinical Research Award. Proc. Am. Assoc. Cancer Res., 2000.